Iradimed Co Stock Price Prediction

IRMD Stock  USD 59.21  1.10  1.82%   
The relative strength index (RSI) of Iradimed's stock price is about 68. This usually indicates that the stock is rather overbought by investors at the present time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Iradimed, making its price go up or down.

Oversold Vs Overbought

68

 
Oversold
 
Overbought
The successful prediction of Iradimed's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Iradimed and does not consider all of the tangible or intangible factors available from Iradimed's fundamental data. We analyze noise-free headlines and recent hype associated with Iradimed Co, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Iradimed's stock price prediction:
Quarterly Earnings Growth
(0)
EPS Estimate Next Quarter
0.39
EPS Estimate Current Year
1.66
EPS Estimate Next Year
1.75
Wall Street Target Price
65
Using Iradimed hype-based prediction, you can estimate the value of Iradimed Co from the perspective of Iradimed response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Iradimed using Iradimed's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Iradimed using crowd psychology based on the activity and movement of Iradimed's stock price.

Iradimed Implied Volatility

    
  0.47  
Iradimed's implied volatility exposes the market's sentiment of Iradimed Co stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Iradimed's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Iradimed stock will not fluctuate a lot when Iradimed's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Iradimed to buy its stock at a price that has no basis in reality. In that case, they are not buying Iradimed because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Iradimed after-hype prediction price

    
  USD 59.21  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.

Prediction based on Rule 16 of the current Iradimed contract

Based on the Rule 16, the options market is currently suggesting that Iradimed Co will have an average daily up or down price movement of about 0.0294% per day over the life of the 2025-04-17 option contract. With Iradimed trading at USD 59.21, that is roughly USD 0.0174 . If you think that the market is fully incorporating Iradimed's daily price movement you should consider acquiring Iradimed Co options at the current volatility level of 0.47%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Check out Iradimed Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
53.2967.3669.25
Details
Naive
Forecast
LowNextHigh
57.3959.2861.17
Details
2 Analysts
Consensus
LowTargetHigh
59.1565.0072.15
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.410.410.42
Details

Iradimed After-Hype Price Prediction Density Analysis

As far as predicting the price of Iradimed at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Iradimed or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Iradimed, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Iradimed Estimiated After-Hype Price Volatility

In the context of predicting Iradimed's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Iradimed's historical news coverage. Iradimed's after-hype downside and upside margins for the prediction period are 57.32 and 61.10, respectively. We have considered Iradimed's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
59.21
59.21
After-hype Price
61.10
Upside
Iradimed is very steady at this time. Analysis and calculation of next after-hype price of Iradimed is based on 3 months time horizon.

Iradimed Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Iradimed is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Iradimed backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Iradimed, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.32 
1.89
  0.06 
  0.05 
8 Events / Month
11 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
59.21
59.21
0.00 
994.74  
Notes

Iradimed Hype Timeline

Iradimed is currently traded for 59.21. The entity has historical hype elasticity of 0.06, and average elasticity to hype of competition of -0.05. Iradimed is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is currently at 0.32%. %. The volatility of related hype on Iradimed is about 1118.15%, with the expected price after the next announcement by competition of 59.16. About 37.0% of the company shares are held by company insiders. The company last dividend was issued on the 15th of November 2024. Given the investment horizon of 90 days the next expected press release will be in about 8 days.
Check out Iradimed Basic Forecasting Models to cross-verify your projections.

Iradimed Related Hype Analysis

Having access to credible news sources related to Iradimed's direct competition is more important than ever and may enhance your ability to predict Iradimed's future price movements. Getting to know how Iradimed's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Iradimed may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
LUNGPulmonx Corp(0.28)9 per month 0.00 (0.02) 8.44 (5.32) 20.44 
OFIXOrthofix Medical 0.56 9 per month 1.70  0.08  3.14 (3.15) 12.11 
NPCENeuropace(0.04)10 per month 2.94  0.23  9.73 (6.20) 35.79 
ITGRInteger Holdings Corp 1.85 9 per month 1.25  0.08  1.88 (1.86) 9.03 
GKOSGlaukos Corp 0.65 10 per month 1.61  0.09  4.77 (2.98) 13.23 
HSKAHeska 0.15 8 per month 0.00  0.19  3.63 (0.71) 21.36 
CNMDCONMED(1.86)10 per month 1.87  0.08  4.46 (2.69) 10.91 
OSAProSomnus, Common Stock 0 1 per month 13.81  0.13  51.22 (20.31) 168.97 
LIVNLivaNova PLC(2.51)8 per month 0.00 (0.09) 2.90 (2.87) 9.56 
ELMDElectromed(1.36)9 per month 1.99  0.20  5.82 (3.90) 12.17 
KIDSOrthopediatrics Corp 0.45 10 per month 0.00 (0.03) 4.85 (6.44) 16.22 
SRDXSurModics(0.23)9 per month 0.00 (0.15) 1.68 (1.84) 9.34 
SGHTSight Sciences(0.09)10 per month 0.00 (0.24) 6.65 (8.24) 17.90 
ANIKAnika Therapeutics 0.34 5 per month 0.00 (0.12) 3.02 (3.39) 32.07 

Iradimed Additional Predictive Modules

Most predictive techniques to examine Iradimed price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Iradimed using various technical indicators. When you analyze Iradimed charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Iradimed Predictive Indicators

The successful prediction of Iradimed stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Iradimed Co, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Iradimed based on analysis of Iradimed hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Iradimed's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Iradimed's related companies.
 2023 2024 2025 (projected)
Dividend Yield0.02210.02540.0316
Price To Sales Ratio9.1310.499.61

Story Coverage note for Iradimed

The number of cover stories for Iradimed depends on current market conditions and Iradimed's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Iradimed is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Iradimed's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Iradimed Short Properties

Iradimed's future price predictability will typically decrease when Iradimed's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Iradimed Co often depends not only on the future outlook of the potential Iradimed's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Iradimed's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding12.7 M
Cash And Short Term Investments49.8 M

Complementary Tools for Iradimed Stock analysis

When running Iradimed's price analysis, check to measure Iradimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iradimed is operating at the current time. Most of Iradimed's value examination focuses on studying past and present price action to predict the probability of Iradimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iradimed's price. Additionally, you may evaluate how the addition of Iradimed to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Valuation
Check real value of public entities based on technical and fundamental data